Recombinant multi-species PAM16 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PAM16 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a mitochondrial protein involved in granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling. This protein also plays a role in the import of nuclear-encoded mitochondrial proteins into the mitochondrial matrix and may be important in reactive oxygen species (ROS) homeostasis. Mutations in this gene cause Megarbane-Dagher-Melike type spondylometaphyseal dysplasia, an early lethal skeletal dysplasia characterized by short stature, developmental delay and other skeletal abnormalities. [provided by RefSeq, May 2017]
The Alternative Names of target: 2010110I09Rik,CGI-136,MAGMAS,Magmas,Mitochondria-associated granulocyte macrophage CSF-signaling molecule,Mitochondrial import inner membrane translocase subunit TIM16,PAM16,Pam16,Presequence translocated-associated motor subunit PAM16,SMDMDM,TIM16,TIMM16,Tim16,Timm16

Target products collectionGo to PAM16 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP9251-Ag-1/ GM-Tg-hg-IP9251-Ag-2 Human PAM16 protein Human
GM-Tg-rg-IP9251-Ag-1/ GM-Tg-rg-IP9251-Ag-2 Rat PAM16 protein Rat
GM-Tg-mg-IP9251-Ag-1/ GM-Tg-mg-IP9251-Ag-2 Mouse PAM16 protein Mouse
GM-Tg-cynog-IP9251-Ag-1/ GM-Tg-cynog-IP9251-Ag-2 Cynomolgus/Rhesus macaque PAM16 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP9251-Ag-1/ GM-Tg-felg-IP9251-Ag-2 Feline PAM16 protein Feline
GM-Tg-cang-IP9251-Ag-1/ GM-Tg-cang-IP9251-Ag-2 Canine PAM16 protein Canine
GM-Tg-bovg-IP9251-Ag-1/ GM-Tg-bovg-IP9251-Ag-2 Bovine PAM16 protein Bovine
GM-Tg-equg-IP9251-Ag-1/ GM-Tg-equg-IP9251-Ag-2 Equine PAM16 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP9251-Ag-1/ GM-Tg-hg-IP9251-Ag-2; GM-Tg-rg-IP9251-Ag-1/ GM-Tg-rg-IP9251-Ag-2;
GM-Tg-mg-IP9251-Ag-1/ GM-Tg-mg-IP9251-Ag-2; GM-Tg-cynog-IP9251-Ag-1/ GM-Tg-cynog-IP9251-Ag-2;
GM-Tg-felg-IP9251-Ag-1/ GM-Tg-felg-IP9251-Ag-2; GM-Tg-cang-IP9251-Ag-1/ GM-Tg-cang-IP9251-Ag-2;
GM-Tg-bovg-IP9251-Ag-1/ GM-Tg-bovg-IP9251-Ag-2; GM-Tg-equg-IP9251-Ag-1/ GM-Tg-equg-IP9251-Ag-2
Products Name PAM16 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PAM16
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PAM16 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.